Brief: Nanthealth announces exclusive agreement with Oncotest-Teva
06/12/2016 19:51
Dec 6 (Reuters) - Nanthealth Inc NH.O :
* Under terms of agreement, Oncotest-Teva will have
exclusive rights to distribute GPS cancer to physicians in
Israel.
* Nanthealth announces exclusive reseller agreement for GPS
cancer(tm) with Oncotest-Teva in Israel
Source text for Eikon: ID:nBw1M15NQa
Further company coverage: NH.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Nanthealth
See all newsNantHealth plunges on Nasdaq share suspension notice
Brief: Nanthealth Inc On May 22 Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On May 24
Brief: NantHealth Announces 1-For-15 Reverse Stock Split
NantHealth Inc reports results for the quarter ended in March - Earnings Summary
Brief: NantHealth Reports 2022 First Quarter Financial Results